Quality FDA Tracker

Audit Readiness by FDA Six Systems

FDA publishes 4,000+ Form 483s per year containing 12,000-16,000 individual observations. FDA Tracker classifies every observation against the QSIT framework automatically, routes intelligence to system owners, and generates audit checklists weighted by current citation frequency.

Key Highlights

01 Every 483 auto-classified to the relevant Six System subsystem
02 Per-system intelligence feeds weighted by citation frequency
03 FDA inspection checklists per system owner — not generic GMP questions
04 Cross-system dependency mapping for cascading citations

Regulatory Context

Cited Across All Six Systems

21 CFR 211.22 Quality System
1 / 6

Critical SOPs still in draft during active manufacturing — QCU oversight gaps across CAPA, OOS, and batch records

The quality control unit had not finalized critical SOPs — including CAPA, OOS Results, and Batch Records — that remained in draft during active manufacturing. Batch records were not reviewed before distribution, and cleanroom certification reports were not reviewed by QA before producing sterile products.

Apothecary Pharma LLC · 2025-05-15
21 CFR 211.68 Production System
2 / 6

New API manufacturing equipment used in production without completing qualification protocol

Equipment qualification procedures were not followed for new API manufacturing equipment. The firm had documented procedures requiring performance qualification before production use, but these were not executed for recently installed equipment.

Cipla Limited · 2024-04-04
21 CFR 211.160 Laboratory Controls
3 / 6

Systematic laboratory instrument oversight failures — expired EM plates, unaddressed balance errors, BET reader errors post-PQ

Laboratory control mechanisms were not established across three areas: expired EM plates without final disposition, analytical balance errors not investigated, and BET kinetic software reader errors post-PQ with the system released for use regardless.

Biocon Biologics Limited · 2025-09-03
21 CFR 211.67 Facilities & Equipment
4 / 6

Rust in HEPA filters of QC microbiology laminar flow hood — inadequate equipment maintenance in controlled environment

Equipment in the QC microbiological laboratory was not adequately maintained. Inspection revealed rust in the HEPA filters of a Laminar Flow Hood used for microbiological testing.

Genzyme Ireland Limited · 2025-01-17
21 CFR 211.84 Materials System
5 / 6

Five-year gap in supplier qualification and raw material testing — incoming materials accepted on COA alone

Supplier qualification and raw material testing had not been conducted since 2019 — a gap of over five years. Incoming materials were accepted solely on supplier certificates of analysis without periodic revalidation.

Nubratori, Inc · 2024-07-26
21 CFR 211.192 Cross-System Overlap
6 / 6

Wrong operator documented for aseptic intervention, CAPA not implemented for visual inspection defect — QCU record accuracy failure

The operator identified as performing a Grade A intervention was not the same operator who received gown monitoring. A CAPA was not implemented for a deviation identifying a defect category missing from the visual inspection kit.

NerPharMa S.r.l. · 2025-06-27

The Problem

Why System Owners Are Not Audit-Ready

Challenge 1 1 / 6

4,000+ Observations Per Year — No Human Can Categorise Them All

  • Most quality teams review only a fraction, missing observations relevant to their systems
  • Manual categorisation is subjective — the same observation gets tagged differently by different analysts
  • By the time a trend is visible through manual review, it has been active for 6-12 months
Challenge 2 2 / 6

One Analyst Is the Bottleneck for Every System Owner

  • When the analyst is pulled into an active inspection, intelligence distribution stops
  • All system owners receive information at the same cadence regardless of citation volume
  • Email-based distribution creates no auditable record of review or action
Challenge 3 3 / 6

Generic Checklists Treat Every System Equally

  • Equal preparation time on Packaging & Labeling (4% of citations) and Lab Controls (23%) misallocates resources
  • Static checklists do not adapt when FDA shifts enforcement focus
  • System owners cannot see whether their citation frequency is rising or declining
Challenge 4 4 / 6

No Cross-System Trend Visibility

  • The most serious 483s cite failures propagating across 2-3 systems
  • Quality System citations originating from Production or Lab Controls gaps are misattributed
  • No mechanism to identify when a trend in one system will cascade into another
Challenge 5 5 / 6

System Owners Prepare in Silos

  • A facility may be prepared in Production but exposed in Lab Controls — with no unified dashboard
  • System owners cannot compare readiness against industry citation patterns
  • Pre-inspection war rooms are organised by system but fed by a single overloaded analyst
Challenge 6 6 / 6

No Mechanism to Track Whether Intelligence Was Acted On

  • Regulatory intelligence emails sit unread during production crises
  • No audit trail connecting an industry observation to a facility self-assessment
  • Most companies cannot demonstrate a systematic process for monitoring industry trends

Audit Readiness by Six Systems in FDA Tracker

1

Automatic Observation-to-System Classification

FDA Tracker classifies every 483 observation against FDA's Six System framework. AI agents parse observation text, identify the primary system, and flag cross-system dependencies.

QSIT System Mapping Cross-System Detection CFR-to-System Linking Automated Tagging

FDA Sources

483 Observations
Warning Letters
QSIT Framework

AI Classification

NLP Extraction
System Mapping
Cross-System Detection

Six System Feeds

Quality System
Production System
Laboratory Controls
2

System-Specific Intelligence Feeds

Each system has its own intelligence feed showing observations, trends, and citation frequency. System owners subscribe to their feed and receive only what is relevant to their area.

System Owner Routing Citation Frequency Trending Recency Weighting Alert Prioritisation
3

Citation Trend Analytics per System

FDA Tracker tracks citation frequency for each system over time, showing which systems face increasing FDA scrutiny. System owners see trends before they become industry talking points.

Time-Series Analysis Quarter-over-Quarter Comparison System Heatmaps Emerging Signal Detection
4

System-Specific Audit Checklists

For each system, FDA Tracker generates an audit readiness checklist weighted by citation frequency — the most commonly cited gaps appear first. Each system owner gets a focused, actionable checklist.

Observation Aggregation Frequency Weighting Question Synthesis PDF Generation
5

Cross-System Risk Visibility

FDA Tracker maps dependencies across systems — showing how a Quality System CAPA failure connects to a Production System validation gap. The Head of Quality sees a unified view of cross-system risk.

Dependency Mapping Propagation Analysis Unified Risk Scoring Executive Dashboard Generation
6

Continuous Readiness Monitoring

Instead of a 4-6 week pre-inspection scramble, FDA Tracker provides continuous monitoring. When FDA shifts focus, system owners are alerted and checklists update automatically.

Real-Time System Tracking Trend Deviation Alerts Checklist Auto-Update Readiness Score Recalculation

The Solution

How FDA Tracker Solves This

Automated QSIT classification, per-system checklists, and continuous readiness monitoring.

FDA Tracker Six System Intelligence

Every Observation Classified by FDA's Six System Inspection Framework

FDA Tracker classifies every 483 observation and warning letter finding against the QSIT Six System framework. AI agents parse observation text, identify primary and secondary systems, and route intelligence to system owners automatically.

  • Automatic QSIT system classification for every FDA enforcement action
  • Cross-system dependency detection when observations span multiple systems
  • Per-system intelligence feeds weighted by citation frequency
System-Specific Audit Checklists

Enforcement-Weighted Checklists for Each of the Six Systems

For each QSIT system, FDA Tracker generates audit readiness checklists weighted by citation frequency — the most commonly cited gaps appear first.

  • Per-system checklists generated from real 483 observations
  • Citation frequency weighting — high-risk questions prioritised
  • Exportable PDF reports for each system owner
Cross-System Trend Analytics

See Which Systems FDA Is Focusing On — Before It Reaches Your Facility

FDA Tracker tracks citation frequency across all six systems over time, surfacing trends invisible through manual monitoring.

  • System-level citation trends with quarter-over-quarter comparison
  • Emerging signal detection when citation rates deviate from historical baselines
  • Category heatmaps showing enforcement focus by system, dosage form, and geography
Continuous Readiness Monitoring

Replace the Pre-Inspection Scramble with Continuous Intelligence

Instead of a 4-6 week fire drill, FDA Tracker provides continuous enforcement intelligence per system. When FDA shifts focus, checklists update and system owners are alerted automatically.

  • Real-time enforcement monitoring with per-system alert routing
  • Automatic checklist updates when enforcement patterns shift
  • Continuous readiness scoring across all six systems

Before & After

The Shift

Dimension
Manual Approach
FDA Tracker
Observation categorisation
One analyst reading 483s manually — 45 min per 483, covering a fraction of FDA output
Every observation auto-classified to the relevant Six System subsystem within minutes of publication
System owner intelligence
Periodic email summaries from regulatory analyst — same cadence for all systems
Dedicated per-system intelligence feeds with citation frequency weighting and trend analytics
Audit checklists
Generic checklists treating all six systems equally — static, updated annually
System-specific checklists weighted by current enforcement data — updated continuously
Cross-system visibility
Observations categorised into a single system — cross-system dependencies invisible
Cross-system dependency mapping showing how citations in one system propagate to others
Trend detection
Trends discovered at conferences or through consultant briefings — 12-18 months behind
Real-time system-level citation trends with quarter-over-quarter comparison and emerging signal detection
Actionability
No feedback loop — intelligence sent but no tracking of whether it was reviewed or acted on
Structured checklist completion with auditable records of review and response

Results

Platform Performance

Based on FDA Tracker's automated classification versus manual analyst workflows.

100%
System Classification
Of FDA observations automatically classified to the relevant Six System subsystem — replacing manual analyst categorisation
6 systems
System Coverage
Complete audit readiness coverage across all six QSIT systems with dedicated intelligence feeds and checklists per system
95%
Categorisation Time
Less time categorising — FDA Tracker classifies each 483 to its QSIT system in seconds versus 45 minutes of manual analyst review
3 months
Trend Detection
Earlier detection of emerging enforcement trends by system — before conference presentations or consultant briefings

Next Step

Get Started

Your system owners are all waiting for the same overloaded analyst to read the same 483s. FDA Tracker classifies every observation by system automatically and gives each owner their own enforcement-weighted intelligence feed.

Get Started
Exit